The production of the new HIV/TB guidelines entails several benefits to countries in the OECS region:
- Programme standardisation
There is now added capacity for standardisation in the clinical management of TB, TB/HIV and also the opportunity to make programmatic changes to align with the increasingly integrated TB and HIV programmes.
This augurs well for health systems strengthening and providing integrated care at all levels.
- Benchmark implementation
These guidelines provide an opportunity to set benchmarks for laboratory diagnostics and testing for TB, TB/HIV so that they are in line with international standards.
Guidelines will also help to harmonise the treatment of HIV and TB patients and are aligned with the recently updated OECS HIV/STI guidelines 2017.
The OECS region is one step closer to having optimal clinical and programmatic standards for the treatment, care and support of patients with TB and TB/HIV.
The HIV/TB Elimination Project remains resolute in achieving the strategic goal of TB Elimination in the OECS region by 2050 and AIDS by 2030.